Approval · Notice of Compliance 22041 · 2019
TRUXIMA: Notice of Compliance 22041
Issued April 4, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22041
- Date
- April 4, 2019
- Company
- Celltrion Healthcare Co Ltd
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other